uniQure N.V.
NASDAQ:QUREBiotechnology
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
Volume 1.16M
Average 1.75M
Returns on capital
uniQure N.V. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-100.0%
avg 266.1%
ROIC
-24.5%
avg -26.3%
ROA
-24.1%
avg -25.7%
Analysis
ROA is currently the strongest return metric at -24.1% versus its period average of -25.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Matthew Craig Kapusta | Chief Executive Officer & Executive Director | USD 1.05M | 54 | — | — |
Walid Abi-Saab | Chief Medical Officer | USD 945.28K | 61 | 166.99K | 0.26% |
Christian Klemt | Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site | USD 759.95K | 53 | 63.90K | 0.10% |
Richard Porter | Chief Business & Scientific Officer | USD 732.17K | 58 | — | — |
Jeannette Potts | Chief Legal & Compliance Officer and Corporate Secretary | USD 712.83K | 64 | 133.25K | 0.21% |
Chiara Elizabeth Russo | Senior Director of Investor Relations | — | — | — | — |
Amin Abujoub | Chief Technical Operations Officer | — | — | — | — |
Tamara Tugal | Business Development Director | — | — | — | — |
Erin Boyer | Chief People & Culture Officer | — | — | — | — |
Hugo Katus | Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 30, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
53
$20.23M
Net Transaction Value
−$20.23M
Net selling
Most Active
Kapusta Matthew C
16 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 6, 26Nov 6, 2026 | Meek David D. Direct | Sell | $193K$192,950.00 |
| Jul 2, 26Jul 2, 2026 | Kapusta Matthew C Direct | Sell | $408.8K$408,756.00 |
| Jul 2, 26Jul 2, 2026 | Kapusta Matthew C Direct | Sell | $194.5K$194,531.26 |
| Jul 2, 26Jul 2, 2026 | Kapusta Matthew C Direct | Sell | $348.8K$348,764.00 |
| Jun 30, 26Jun 30, 2026 | Kaye Jack Direct | Sell | $190.9K$190,934.43 |
| Jun 30, 26Jun 30, 2026 | Abi-Saab Walid Direct | Sell | $464.6K$464,600.00 |
| Jun 30, 26Jun 30, 2026 | Abi-Saab Walid Direct | Sell | $928K$928,000.00 |
| Jun 30, 26Jun 30, 2026 | Kaye Jack Direct | Sell | $792.1K$792,095.80 |
| Jun 26, 26Jun 26, 2026 | Abi-Saab Walid Direct | Sell | $67.2K$67,197.24 |
| Jun 25, 26Jun 25, 2026 | Kapusta Matthew C Direct | Sell | $1.4M$1,436,374.32 |
1–10 of 53
Summary
Insiders reported 0 buys worth $0.00 and 53 sells worth $20.23M over the last 12 months. That adds up to net selling of $20.23M. Kapusta Matthew C was the most active insider with 16 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A4 analysts |
| Revenue | N/A | N/A | -46.7% | +118.5% (5yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | N/A | N/A6 analysts |
Analysis
Recent growth has been strongest in Revenue at -46.7% over three years. Forward estimates point to Revenue at +118.5% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does uniQure N.V. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about QURE's management, answered from reported figures.
Who manages QURE?
uniQure N.V. (QURE) lists 10 active executives. The top listed executive is Christian Klemt, Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site.
Are QURE insiders buying or selling?
Recent insider activity shows net selling of $23.11M.
Continue the stock analysis
Jump to another research area for this company.